Systematic Analysis of Drug Vulnerabilities Conferred by Tumor Suppressor Loss
Summary: In addition to oncogene inhibition, targeting tumor suppressor deficiency could provide potential venues for precision cancer medicine. However, the full spectrum of drug vulnerability conferred by tumor suppressor loss remains unclear. We systematically analyzed how loss of 59 common tumor...
Main Authors: | Hongyu Ding, Jie Zhao, Yanli Zhang, Jiao Yu, Mingxian Liu, Xiaoxi Li, Liang Xu, Minghui Lin, Chuan Liu, Zhengjin He, Shishuang Chen, Hai Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124719306631 |
Similar Items
-
UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma
by: Xiaoxi Li, et al.
Published: (2018-07-01) -
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
by: Agnieszka K. Witkiewicz, et al.
Published: (2018-01-01) -
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
by: Witkiewicz, Agnieszka K., et al.
Published: (2018) -
Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma
by: Haitang Yang, et al.
Published: (2020-08-01) -
Loss of the RB tumor suppressor contributes to genomic instability
by: SRINIVASAN, SEETHA V.
Published: (2008)